Author Archives: Susan Peters

Why do Clinical Studies Fail to Complete?

According to ClinicalTrials.gov, 3% (n=361) of all Phase 3 studies started from 2013 through 2017 terminated early. While that appears to be a relatively low rate, each of these instances represents millions to tens of millions of dollars in expenditure. Low Enrollment Highlighting the challenges with feasibility, incorporating Quality by...

Read More

TayganPoint is Proud to be Re-Certified by WBENC as a Women Owned Business

TayganPoint Consulting Group was recently re-certified as a woman owned business by the Women’s Business Enterprise National Council (WBENC). This is the 9th successive year of affiliation for TayganPoint.  WBENC, founded in 1997, is the nation’s leading advocate of women-owned businesses as suppliers to America’s corporations. It is the largest third-party certifier of businesses...

Read More

Social Responsibility: Life Science Leadership’s Next Secret Weapon

Entering Merck soon after Ken Frazier stepped down from President Trump’s Manufacturing Council, I was struck with newfound feelings of trust, connection and pride. Walking the halls, I found hundreds of people, from all backgrounds, ethnicities, ages enroute to contribute to Merck, it’s vision, and its mission. With recent events...

Read More

The Do’s and Don’ts of Business Transformation

On Oct. 12 Healthcare Businesswomen’s Association hosted a panel exploring the successes and failures of business transformation in life sciences. The panelists, who have all thankfully lived to tell the tale, shared their transformation do’s and don’ts based on pitfalls and successes of their endeavors. Transformation truly touches every level of...

Read More

NATALIE GERDT LOTIER  | Vice President and Head of Established Brand Operations Bristol Myers Squibb

NATALIE GERDT LOTIER   Vice President and Head of Established Brand Operations Bristol Myers Squibb A strategic, innovative and visionary executive in global supply chain & manufacturing, Natalie has over 25 years of deep and broad experience in the Biopharma industry. In her current role, she is defining an integrated multi-functional...

Read More

EMILY CHU | Vice President of Consumer Supply Chain, Information Management of Johnson & Johnson

EMILY CHU Vice President of Consumer Supply Chain, Information Management of Johnson & Johnson Passionate about applying IT as a core capability to drive profitable growth and innovation, Emily is responsible for the Global Supply Chain IT organization for Consumer. Emily has held leadership positions in Supply Chain, Finance and...

Read More

Managing a Portfolio of Drug Development Projects: How to Find More Certainty in an Uncertain World

The drug development business is fraught with uncertainty.  Unpredictability in discovering and testing new molecular compounds or biologics – ranging from the scientific, operational, financial, regulatory, and organizational – are inherent parts of the process. This article is not about forever-eliminating uncertainty in the drug development process; that will never...

Read More

Archives